DOD restricts OTC aspirin in combat areas
This article was originally published in The Tan Sheet
The Department of Defense says military members and other personnel in combat areas should not use aspirin products unless directed by a physician because use of the common OTC drug can cause excessive blood loss if a person is injured or undergoes surgery. The department April 9 directed the Army and Air Force Exchange Service retail outlets and other Morale, Welfare and Recreation Activities facilities to discontinue sales of OTC aspirin products in war zone areas, DOD says, noting pulled products include Bayer, Excedrin and Alka-Seltzer aspirins. Outlets began removing the products April 14. Retailers should sell OTC products with ibuprofen, acetaminophen and naproxen, DOD says in an April 30 release
You may also be interested in...
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.
Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.